[1]
|
Martin-Rodriguez, E., Guillen-Grima, F., Martí, A., et al. (2015) Comorbidity Associated with Obesity in a Large Popu-lation: The APNA Study. Obesity Research & Clinical Practice, 9, 435-447.
https://doi.org/10.1016/j.orcp.2015.04.003
|
[2]
|
张彦康, 张婷, 李雨, 等. 肥胖治疗的挑战与希望[J]. 自然杂志, 2022, 44(6): 469-479.
|
[3]
|
Csige, I., Ujvárosy, D., Szabó, Z., et al. (2018) The Impact of Obesity on the Cardio-vascular System. Journal of Diabetes Research, 2018, Article ID: 3407306. https://doi.org/10.1155/2018/3407306
|
[4]
|
Lahey, R. and Khan, S.S. (2018) Trends in Obesity and Risk of Cardi-ovascular Disease. Current Epidemiology Reports, 5, 243-251. https://doi.org/10.1007/s40471-018-0160-1
|
[5]
|
Ojalehto, E., Zhan, Y., Jylhävä, J., et al. (2023) Genetically and Environmentally Predicted Obesity in Relation to Cardiovascular Disease: A Nationwide Cohort Study. EClinicalMedi-cine, 58, Article 101943.
https://doi.org/10.1016/j.eclinm.2023.101943
|
[6]
|
王滢莹, 秦俭, 程丽芳. 肥胖悖论与心血管疾病[J]. 心血管病学进展, 2022, 43(1): 52-55.
|
[7]
|
López-Díez, R., Shekhtman, A., Ramasamy, R., et al. (2016) Cellular Mechanisms and Consequences of Glycation in Atherosclerosis and Obesity. Biochimica et Biophysica Acta, 1862, 2244-2252.
https://doi.org/10.1016/j.bbadis.2016.05.005
|
[8]
|
Koliaki, C., Liatis, S. and Kokkinos, A. (2019) Obesity and Car-diovascular Disease: Revisiting an Old Relationship. Metabolism: Clinical and Experimental, 92, 98-107. https://doi.org/10.1016/j.metabol.2018.10.011
|
[9]
|
Raman, P. and Khanal, S. (2021) Leptin in Atherosclerosis: Focus on Macrophages, Endothelial and Smooth Muscle Cells. International Journal of Molecular Sciences, 22, Article 5446. https://doi.org/10.3390/ijms22115446
|
[10]
|
Koleva, D.I., Orbetzova, M.M., Nikolova, J.G., et al. (2016) Pathophysiological Role of Adiponectin, Leptin and Asymmetric Dimethylarginine in the Process of Atherosclerosis. Fo-lia Medica, 58, 234-240.
https://doi.org/10.1515/folmed-2016-0039
|
[11]
|
Choi, K.M. (2016) The Impact of Organokines on Insulin Re-sistance, Inflammation, and Atherosclerosis. Endocrinology and Metabolism, 31, 1-6. https://doi.org/10.3803/EnM.2016.31.1.1
|
[12]
|
Feng, Y., Ye, D., Wang, Z., et al. (2022) The Role of Interleukin-6 Family Members in Cardiovascular Diseases. Frontiers in Cardiovascular Medicine, 9, Article 818890. https://doi.org/10.3389/fcvm.2022.818890
|
[13]
|
Zhou, L., Li, J.Y., He, P.P., et al. (2021) Resistin: Potential Bi-omarker and Therapeutic Target in Atherosclerosis. Clinica Chimica Acta, 512, 84-91. https://doi.org/10.1016/j.cca.2020.11.010
|
[14]
|
Hoffmann, A., Ebert, T., Klöting, N., et al. (2016) Leptin Dose-Dependently Decreases Atherosclerosis by Attenuation of Hypercholesterolemia and Induction of Adiponectin. Bi-ochimica et Biophysica Acta, 1862, 113-120.
https://doi.org/10.1016/j.bbadis.2015.10.022
|
[15]
|
Beltowski, J. (2006) Leptin and Atherosclerosis. Atherosclerosis, 189, 47-60.
https://doi.org/10.1016/j.atherosclerosis.2006.03.003
|
[16]
|
Stancel, N., Chen, C.C., Ke, L.Y., et al. (2016) Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis. Clinical Chemistry, 62, 320-327.
https://doi.org/10.1373/clinchem.2015.243923
|
[17]
|
Lee, J., Ha, S.J., Park, J., et al. (2020) Arctium lappa Root Ex-tract Containing L-Arginine Prevents TNF-α-Induced Early Atherosclerosis in Vitro and in Vivo. Nutrition Research (New York, NY), 77, 85-96.
https://doi.org/10.1016/j.nutres.2020.03.003
|
[18]
|
Kitagawa, T., Yamamoto, H., Hattori, T., et al. (2018) Tumor Necrosis Factor-α Gene Expression in Epicardial Adipose Tissue Is Related to Coronary Atherosclerosis Assessed by Computed Tomography. Journal of Atherosclerosis and Thrombosis, 25, 269-280. https://doi.org/10.5551/jat.41178
|
[19]
|
Ragab, S.M., Safan, M.A., Obeid, O.M., et al. (2015) Lipopro-tein-Associated Phospholipase A2 (Lp-PLA2) and Tumor Necrosis Factor-Alpha (TNF-α) and Their Relation to Prema-ture Atherosclerosis in β-Thalassemia Children. Hematology (Amsterdam, Netherlands), 20, 228-238. https://doi.org/10.1179/1607845414Y.0000000180
|
[20]
|
Hamid, A.A., Aminuddin, A., Anuar, N.N.M., et al. (2022) Persicaria minor (Huds.) Opiz Prevents in Vitro Atherogenesis by Attenuating Tumor Necrosis Factor-α-Induced Monocyte Adhesion to Human Umbilical Vein Endothelial Cells. Life (Basel, Switzerland), 12, Article 1462. https://doi.org/10.3390/life12101462
|
[21]
|
Ozcan, L. and Tabas, I. (2016) Calcium Signalling and ER Stress in In-sulin Resistance and Atherosclerosis. Journal of Internal Medicine, 280, 457-464. https://doi.org/10.1111/joim.12562
|
[22]
|
Striukova, E.V., Shramko, V.S., Kashtanova, E.V., et al. (2022) Adi-pokine Levels in Men with Coronary Atherosclerosis on the Background of Abdominal Obesity. Journal of Personalized Medicine, 12, Article 1248.
https://doi.org/10.3390/jpm12081248
|
[23]
|
Reardon, C.A., Lingaraju, A., Schoenfelt, K.Q., et al. (2018) Obesity and Insulin Resistance Promote Atherosclerosis through an IFNγ-Regulated Macrophage Protein Network. Cell Reports, 23, 3021-3030.
https://doi.org/10.1016/j.celrep.2018.05.010
|
[24]
|
Jahangir, E., De Schutter, A. and Lavie, C.J. (2014) The Rela-tionship between Obesity and Coronary Artery Disease. Translational Research: The Journal of Laboratory and Clinical Medicine, 164, 336-344.
https://doi.org/10.1016/j.trsl.2014.03.010
|
[25]
|
Mandviwala, T., Khalid, U. and Deswal, A. (2016) Obesity and Cardiovascular Disease: A Risk Factor or a Risk Marker? Current Atherosclerosis Reports, 18, Article No. 21. https://doi.org/10.1007/s11883-016-0575-4
|
[26]
|
史青云, 陈炳华, 罗婉榕, 等. 成年人不同肥胖评价指标对高血压患病风险预测效果的比较[J]. 西安交通大学学报(医学版), 2022, 43(4): 581-587.
|
[27]
|
Shariq, O.A. and Mckenzie, T.J. (2020) Obesity-Related Hypertension: A Review of Pathophysiology, Management, and the Role of Metabolic Surgery. Gland Surgery, 9, 80-93. https://doi.org/10.21037/gs.2019.12.03
|
[28]
|
Chrysant, S.G. (2019) Pathophysiology and Treatment of Obesity-Related Hypertension. Journal of Clinical Hypertension (Greenwich, Conn), 21, 555-559. https://doi.org/10.1111/jch.13518
|
[29]
|
Lu, S.C. and Akanji, A.O. (2020) Leptin, Obesity, and Hyper-tension: A Review of Pathogenetic Mechanisms. Metabolic Syndrome and Related Disorders, 18, 399-405. https://doi.org/10.1089/met.2020.0065
|
[30]
|
Tagi, V.M., Mainieri, F. and Chiarelli, F. (2022) Hypertension in Pa-tients with Insulin Resistance: Etiopathogenesis and Management in Children. International Journal of Molecular Sci-ences, 23, Article 5814.
https://doi.org/10.3390/ijms23105814
|
[31]
|
Hamzeh, N., Ghadimi, F., Farzaneh, R., et al. (2017) Obesity, Heart Failure, and Obesity Paradox. The Journal of Tehran Heart Center, 12, 1-5.
|
[32]
|
Hatem, S.N. and Sanders, P. (2014) Epicardial Adipose Tissue and Atrial Fibrillation. Cardiovascular Research, 102, 205-213. https://doi.org/10.1093/cvr/cvu045
|
[33]
|
韩素霞, 王娟, 高苏莉, 等. 过表达c-Ski改善心房颤动犬模型心房电重构和结构重构[J]. 国际心血管病杂志, 2021, 48(6): 360-364.
|
[34]
|
Pathak, R.K., Mahajan, R., Lau, D.H., et al. (2015) The Implications of Obesity for Cardiac Arrhythmia Mechanisms and Management. The Canadian Journal of Cardiology, 31, 203-210. https://doi.org/10.1016/j.cjca.2014.10.027
|
[35]
|
Hatem, S.N., Redheuil, A. and Gandjbakhch, E. (2016) Cardiac Adipose Tissue and Atrial Fibrillation: The Perils of Adiposity. Cardiovascular Re-search, 109, 502-509. https://doi.org/10.1093/cvr/cvw001
|
[36]
|
Goudis, C.A., Korantzopoulos, P., Ntalas, I.V., et al. (2015) Obesity and Atrial Fibrillation: A Comprehensive Review of the Pathophysiological Mechanisms and Links. Journal of Cardiology, 66, 361-369.
https://doi.org/10.1016/j.jjcc.2015.04.002
|
[37]
|
Paratz, E.D., Ashokkumar, S., Van Heusden, A., et al. (2022) Obe-sity in Young Sudden Cardiac Death: Rates, Clinical Features, and Insights into People with Body Mass Index > 50 kg/m2. American Journal of Preventive Cardiology, 11, Article 100369. https://doi.org/10.1016/j.ajpc.2022.100369
|
[38]
|
Plourde, B., Sarrazin, J.F., Nault, I., et al. (2014) Sudden Cardiac Death and Obesity. Expert Review of Cardiovascular Therapy, 12, 1099-1110. https://doi.org/10.1586/14779072.2014.952283
|
[39]
|
Finocchiaro, G., Papadakis, M., Dhutia, H., et al. (2018) Obesity and Sudden Cardiac Death in the Young: Clinical and Pathological Insights from a Large National Registry. Eu-ropean Journal of Preventive Cardiology, 25, 395-401.
https://doi.org/10.1177/2047487317751291
|
[40]
|
Remme, C.A. (2022) Sudden Cardiac Death in Diabetes and Obe-sity: Mechanisms and Therapeutic Strategies. The Canadian Journal of Cardiology, 38, 418-426. https://doi.org/10.1016/j.cjca.2022.01.001
|
[41]
|
Banack, H.R. and Kaufman, J.S. (2014) The Obesity Paradox: Un-derstanding the Effect of Obesity on Mortality among Individuals with Cardiovascular Disease. Preventive Medicine, 62, 96-102.
https://doi.org/10.1016/j.ypmed.2014.02.003
|
[42]
|
Alagiakrishnan, K., Banach, M., Ahmed, A., et al. (2016) Com-plex Relationship of Obesity and Obesity Paradox in Heart Failure—Higher Risk of Developing Heart Failure and Better Outcomes in Established Heart Failure. Annals of Medicine, 48, 603-613. https://doi.org/10.1080/07853890.2016.1197415
|
[43]
|
Parto, P., Lavie, C.J., Arena, R., et al. (2016) Body Habitus in Heart Failure: Understanding the Mechanisms and Clinical Significance of the Obesity Paradox. Future Cardiology, 12, 639-653. https://doi.org/10.2217/fca-2016-0029
|